Our findings strongly suggest that eosinophils are activated in cGVHD, since we show that patients with cGVHD have higher levels of the eosinophilic activation markers CD9 and CD69 [38,39] than patients without GVHD. This evidence concerns the gene CD9 and graft versus host disease.